Five9 FIVN 深 滬
等待開盤 08-21 09:30:00 美东时间
32.30
-0.440
-1.34%
華盛通- 最 高33.09
- 今 開32.43
- 成交量 172.02万股
- 最 低 32.1116
- 昨 收 32.74
- 總市值 24.14亿
- 52周最高 34.58
- 市盈率 靜 72.11
- 換手率 2.30%
- 52周最低 13.29
- 委 比 -99.15%
- 總股本 7472.35万
- 歷史最高 211.68
- 量 比 0.87
- 振 幅 2.99%
- 歷史最低 3.48
- 每 手 1
- 風險率 4.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Snowflake, MongoDB receive target hikes after infrastructure software rally: Truist
Several infrastructure software names have rallied over the past few months, due in part to AI-related tailwinds, prompting Truist Securities to increase several price targets. "During earnings, JFrog...
今天 00:12
Workday(WDAY.US)收购传闻后，KeyBanc圈出软件业潜在收购名单：HubSpot(HUBS.US)、Five9(FIVN.US)在列
KeyBanc分析师认为，在上周有报道称银湖资本正就收购Workday进行谈判之后，HubSpot、Five9、阿莎娜、Netskope以及GitLab等公司有望成为下一批潜在的收购对象。
08-19 10:32
HubSpot, Five9, GitLab, Asana potential takeover targets after Workday news - analysts
HubSpot (HUBS), Five9 (FIVN), Asana (ASAN), Netskope (NTSK), and GitLab (GTLB) may be potential takeover targets after last week's report that Silver Lake was in talks to acquire Workday (WDAY), accor...
08-19 00:39
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Friday. Shares of Natera Inc (NASDAQ:NTRA) rose sharply after the company reported better-than-expected quarterly financial results and raised its FY26 sales guidance above estimates. The company reported a second-quarter loss o...
08-08 03:35
Five9 shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Five9 shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
08-07 23:02
Rosenblatt Maintains Buy on Five9, Raises Price Target to $32
Rosenblatt analyst Catharine Trebnick maintains Five9 (NASDAQ:FIVN) with a Buy and raises the price target from $29 to $32.
08-07 19:45
财报速睇 | Five9 2026财年Q2营收3.12亿美元，同比增长10.3%；归母净利润0.03亿美元，同比增长191.8%
华盛资讯8月7日讯，Five9公布2026财年Q2业绩，公司Q2营收3.12亿美元，同比增长10.3%，归母净利润0.03亿美元，同比增长191.8%。
08-07 07:49
财报速睇 | Five9 2026财年Q2营收3.12亿美元，同比增长10.3%；归母净利润0.03亿美元，同比增长191.8%
华盛资讯8月7日讯，Five9公布2026财年Q2业绩，公司Q2营收3.12亿美元，同比增长10.3%，归母净利润0.03亿美元，同比增长191.8%。
08-07 07:19
